Sam-A Pharm. Co. Ltd
009300 | KO
Overview
Corporate Details
- ISIN(s):
- KR7009300005
- LEI:
- Country:
- South Korea
- Address:
- 강원도 원주시 문막읍 동화공단로 49, 원주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-25 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 30.7 KB | ||
| 2025-08-25 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 39.1 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 998.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 1009.9 KB | ||
| 2025-05-13 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 993.0 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.8 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 24.4 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.5 MB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 24.5 KB | ||
| 2025-03-17 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 110.0 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 112.4 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.2 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.1 KB | ||
| 2025-02-26 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.5 KB | ||
| 2024-12-10 00:00 |
Quarterly Report
[기재정정]분기보고서 (2024.09)
|
Korean | 902.6 KB |
Automate Your Workflow. Get a real-time feed of all Sam-A Pharm. Co. Ltd filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Sam-A Pharm. Co. Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sam-A Pharm. Co. Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
South Korea
067370
South Korea
067370
Develops novel oncology/antiviral drugs and commercializes generic pharmaceuticals in Canada.
United States of America
SBFM
United States of America
SBFM
Develops and commercializes therapies for CNS diseases like epilepsy, migraine, and ADHD.
United States of America
SUPN
United States of America
SUPN
Provides medical device coatings, vascular products, and components for diagnostic tests.
United States of America
SRDX
United States of America
SRDX
Develops engineered cancer drugs like ADCs using a cell-free protein synthesis platform.
United States of America
STRO
United States of America
STRO
/other/Swedencare_AB_publ-logo.png){kind=logo}
Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.
Sweden
SECARE
Sweden
SECARE
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden
SOBI
Sweden
SOBI
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan
4582
Japan
4582
Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.
Sweden
SYNACT
Sweden
SYNACT
Developing inhaled interferon beta treatments for severe viral lung infections in hospitalized patients.
United Kingdom
SNG
United Kingdom
SNG